Infectious complications of CAR T-cell therapy: a clinical update

Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary treatment modality used to treat haematological malignancies. Lymphocytes are engineered to produce CARs directed towards tumour cell antigens. Clinical trials have demonstrated impressive malignancy-related outcomes. Unfortunately, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Adam G., Henden, Andrea S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388233/
https://www.ncbi.nlm.nih.gov/pubmed/34457269
http://dx.doi.org/10.1177/20499361211036773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388233/
https://www.ncbi.nlm.nih.gov/pubmed/34457269
http://dx.doi.org/10.1177/20499361211036773

Ejemplares similares